Evidence map›Paper›PMID 35592932›Full record

ArticleHistopathology2022

Current conundrums with cribriform prostate cancer.

Jennifer B Gordetsky, Kerry Schaffer, Paula J Hurley

Abstract readEditorialComment
In one paragraph

Article in Histopathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Contemporary review of prognostic markers of prostate cancer from a pathologist perspective.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2025
    Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jennifer B GordetskyDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-0745-2160
Kerry SchafferDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Paula J HurleyDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.

Funding

Regulation of Metastatic Development by Heritable Variants in the Tumor MicroenvironmentR01CA211695 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HURLEY, PAULA JILL · 2018 to 2023
$1.9M
NCI NIH HHS R01 CA211695
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostatic NeoplasmsHumansMaleNeoplasm Gradingcribriformgermline testingGrade Groupsintraductal carcinomaoutcomesprostate cancerPTEN

Identifiers

PMID35592932
PMCPMC9675397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.